• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic value of lymphovascular invasion in patients with esophageal squamous cell carcinoma.食管鳞状细胞癌患者淋巴管侵犯的预后价值
Ann Transl Med. 2019 Jun;7(12):256. doi: 10.21037/atm.2019.05.23.
2
Lymphovascular invasion predicts disease-specific survival in node-negative esophageal squamous cell carcinoma patients after minimally invasive esophagectomy.淋巴管浸润可预测微创食管切除术后淋巴结阴性食管鳞状细胞癌患者的疾病特异性生存率。
Wideochir Inne Tech Maloinwazyjne. 2022 Jun;17(2):309-316. doi: 10.5114/wiitm.2021.112679. Epub 2022 Jan 19.
3
Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma.脉管侵犯是根治性切除的胸段食管鳞癌的独立预后指标。
Thorac Cancer. 2019 Feb;10(2):150-155. doi: 10.1111/1759-7714.12922. Epub 2018 Nov 28.
4
Lymphovascular Invasion as the Major Prognostic Factor in Node-Negative Esophageal Cancer After Primary Esophagectomy.原发性食管癌根治术后淋巴结阴性患者的淋巴管脉管侵犯是主要预后因素。
J Gastrointest Surg. 2020 Jul;24(7):1459-1468. doi: 10.1007/s11605-019-04310-0. Epub 2019 Jul 3.
5
Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study.淋巴管血管(V)和神经周围(N)侵犯对食管鳞状细胞癌(ESCC)患者生存的影响:单中心回顾性研究。
PeerJ. 2022 Mar 2;10:e12974. doi: 10.7717/peerj.12974. eCollection 2022.
6
The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma.改良的肿瘤-淋巴结-转移分期系统结合淋巴管侵犯在食管鳞状细胞癌患者中的分期表现。
Front Oncol. 2022 Oct 13;12:1018827. doi: 10.3389/fonc.2022.1018827. eCollection 2022.
7
Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.新辅助放化疗治疗的食管鳞状细胞癌患者中淋巴管侵犯的预后意义
Ann Surg Oncol. 2015 Jan;22(1):338-43. doi: 10.1245/s10434-014-3881-5. Epub 2014 Jul 15.
8
Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma.淋巴结阴性食管鳞癌中淋巴管浸润的鉴定和验证及其作为预后和分期因素的意义。
J Thorac Oncol. 2016 Apr;11(4):583-92. doi: 10.1016/j.jtho.2015.12.109. Epub 2016 Jan 11.
9
Occurrence and Prognostic Value of Perineural Invasion in Esophageal Squamous Cell Cancer: A Retrospective Study.食管鳞状细胞癌中神经周围侵犯的发生率及预后价值:一项回顾性研究
Ann Surg Oncol. 2022 Jan;29(1):586-597. doi: 10.1245/s10434-021-10665-z. Epub 2021 Aug 23.
10
Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.术前放化疗后手术治疗的食管鳞状细胞癌患者的预后组织学因素
BMC Cancer. 2017 Jan 19;17(1):62. doi: 10.1186/s12885-017-3063-5.

引用本文的文献

1
F-fluorodeoxyglucose positron emission tomography/computed tomography parameters are associated with histological outcomes in superficial esophageal squamous cell carcinoma.氟-18 脱氧葡萄糖正电子发射断层扫描/计算机断层扫描参数与食管浅表鳞癌的组织学结果相关。
Sci Rep. 2024 Jul 30;14(1):17493. doi: 10.1038/s41598-024-65066-5.
2
A radiomics nomogram based on contrast-enhanced CT for preoperative prediction of Lymphovascular invasion in esophageal squamous cell carcinoma.基于增强CT的影像组学列线图用于术前预测食管鳞状细胞癌的淋巴管侵犯
Front Oncol. 2023 Jul 3;13:1208756. doi: 10.3389/fonc.2023.1208756. eCollection 2023.
3
DOES NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTION CANCER PATIENTS AFFECT POSTOPERATIVE OUTCOMES? A STUDY USING THE BECKER TUMOR REGRESSION GRADE SYSTEM AND LYMPH NODE REGRESSION.新辅助放化疗对食管胃交界部癌患者的术后结局是否有影响?使用贝克尔肿瘤退缩分级系统和淋巴结退缩评估的研究
Arq Bras Cir Dig. 2023 May 5;36:e1724. doi: 10.1590/0102-672020230002e1724. eCollection 2023.
4
Histological prognosticators in neoadjuvant naive oesophageal cancer patients.新辅助未治疗食管癌患者的组织学预后指标
Langenbecks Arch Surg. 2023 May 9;408(1):184. doi: 10.1007/s00423-023-02927-z.
5
The prognostic value of separate lymphatic invasion and vascular invasion in oesophageal squamous cell carcinoma: a meta-analysis and systematic review.单独的淋巴血管侵犯在食管鳞癌中的预后价值:一项荟萃分析和系统评价。
BMC Cancer. 2022 Dec 19;22(1):1329. doi: 10.1186/s12885-022-10441-6.
6
The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma.改良的肿瘤-淋巴结-转移分期系统结合淋巴管侵犯在食管鳞状细胞癌患者中的分期表现。
Front Oncol. 2022 Oct 13;12:1018827. doi: 10.3389/fonc.2022.1018827. eCollection 2022.
7
Can Lymphovascular Invasion be Predicted by Preoperative Contrast-Enhanced CT in Esophageal Squamous Cell Carcinoma?术前增强 CT 是否可预测食管鳞癌的脉管侵犯?
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221111229. doi: 10.1177/15330338221111229.
8
Computed tomography-based radiomics analysis to predict lymphovascular invasion in esophageal squamous cell carcinoma.基于计算机断层扫描的放射组学分析预测食管鳞癌的血管淋巴管侵犯。
Br J Radiol. 2022 Feb 1;95(1130):20210918. doi: 10.1259/bjr.20210918. Epub 2021 Dec 15.
9
Change in Maximal Esophageal Wall Thickness Provides Prediction of Survival and Recurrence in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy and Surgery.最大食管壁厚度的变化可预测食管鳞状细胞癌患者新辅助放化疗及手术后的生存和复发情况。
Cancer Manag Res. 2021 Mar 15;13:2433-2445. doi: 10.2147/CMAR.S295646. eCollection 2021.

本文引用的文献

1
Early-stage (cT2N0) esophageal cancer: Should induction therapy be a standard?早期(cT2N0)食管癌:诱导治疗应成为标准治疗方案吗?
J Thorac Cardiovasc Surg. 2018 May;155(5):2231-2232. doi: 10.1016/j.jtcvs.2018.02.029. Epub 2018 Feb 17.
2
A prediction model for lymph node metastasis in T1 esophageal squamous cell carcinoma.T1 期食管鳞癌淋巴结转移预测模型。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1902-1908. doi: 10.1016/j.jtcvs.2017.11.005. Epub 2017 Nov 11.
3
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.新辅助顺铂和氟尿嘧啶与表柔比星、顺铂和卡培他滨序贯切除治疗食管腺癌患者的疗效比较(英国医学研究理事会OE05研究):一项开放标签的随机3期试验
Lancet Oncol. 2017 Sep;18(9):1249-1260. doi: 10.1016/S1470-2045(17)30447-3. Epub 2017 Aug 4.
4
Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer.肿瘤长度在接受食管癌切除术患者中的预后意义。
J Surg Oncol. 2017 Dec;116(8):1114-1122. doi: 10.1002/jso.24789. Epub 2017 Aug 2.
5
Oesophageal cancer.食管癌。
Lancet. 2017 Nov 25;390(10110):2383-2396. doi: 10.1016/S0140-6736(17)31462-9. Epub 2017 Jun 22.
6
Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies.胃食管癌新辅助治疗后的肿瘤退缩分级与生存情况:17项已发表研究的荟萃分析
Eur J Surg Oncol. 2017 Sep;43(9):1607-1616. doi: 10.1016/j.ejso.2017.03.001. Epub 2017 Mar 18.
7
Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas.可切除食管/食管胃交界腺癌和鳞状细胞癌患者新辅助治疗方案的最新进展
Curr Oncol Rep. 2017 Jan;19(1):7. doi: 10.1007/s11912-017-0559-8.
8
Analysis of Predictors for Lymph Node Metastasis in Patients with Superficial Esophageal Carcinoma.浅表性食管癌患者淋巴结转移的预测因素分析
Gastroenterol Res Pract. 2016;2016:3797615. doi: 10.1155/2016/3797615. Epub 2016 Oct 5.
9
Positive esophageal proximal resection margin: an important prognostic factor for esophageal cancer that warrants adjuvant therapy.食管近端切缘阳性:食管癌的一个重要预后因素,需要辅助治疗。
J Thorac Dis. 2016 Sep;8(9):2512-2518. doi: 10.21037/jtd.2016.08.61.
10
Prognostic Significance of Lymphovascular Invasion for Thoracic Esophageal Squamous Cell Carcinoma.淋巴管侵犯对胸段食管鳞状细胞癌的预后意义
Ann Surg Oncol. 2016 Nov;23(12):4101-4109. doi: 10.1245/s10434-016-5416-8. Epub 2016 Jul 19.

食管鳞状细胞癌患者淋巴管侵犯的预后价值

Prognostic value of lymphovascular invasion in patients with esophageal squamous cell carcinoma.

作者信息

Gu Yi-Min, Yang Yu-Shang, Hu Wei-Peng, Wang Wen-Ping, Yuan Yong, Chen Long-Qi

机构信息

Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.

出版信息

Ann Transl Med. 2019 Jun;7(12):256. doi: 10.21037/atm.2019.05.23.

DOI:10.21037/atm.2019.05.23
PMID:31355223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6614317/
Abstract

BACKGROUND

Whether lymphovascular invasion (LVI) in esophageal squamous cell carcinoma (ESCC) should be considered an independent prognostic factor for survival is controversial. The aim of this report was to investigate the prognostic value of LVI for patients with ESCC.

METHODS

Between October 2010 and July 2011, 152 ESCC patients were retrospectively reviewed. All of the patients underwent curative resection as their primary treatment. Clinicopathological features and overall survival (OS) rate were investigated. Kaplan-Meier curves were used to calculate the OS rate, and the prognostic factors were identified by Cox regression model.

RESULTS

Positive LVI was found in 49 (32.2%) patients. Patients with negative LVI had a significantly better 5-year OS rate than those with positive LVI (52.9% 28.8%; P=0.000). The age, T stage, N stage, tumor differentiation, and LVI were demonstrated to be significant prognostic factors for OS through univariate analyses. LVI was confirmed as an independent prognostic factor for OS through multivariate survival analyses. Subgroup analyses revealed that LVI was associated with a decreased OS in node-negative patients, and no significant difference was observed in node-positive cases.

CONCLUSIONS

Our study highlighted that LVI is an independent prognostic factor in patients with resectable ESCC. LVI may facilitate the stratification of patients with poor survival.

摘要

背景

食管鳞状细胞癌(ESCC)中的淋巴管侵犯(LVI)是否应被视为生存的独立预后因素存在争议。本报告的目的是研究LVI对ESCC患者的预后价值。

方法

回顾性分析2010年10月至2011年7月期间的152例ESCC患者。所有患者均接受了根治性切除术作为主要治疗方法。研究了临床病理特征和总生存率(OS)。采用Kaplan-Meier曲线计算OS率,并通过Cox回归模型确定预后因素。

结果

49例(32.2%)患者LVI阳性。LVI阴性患者的5年OS率明显高于LVI阳性患者(52.9%对28.8%;P=0.000)。通过单因素分析,年龄、T分期、N分期、肿瘤分化和LVI被证明是OS的重要预后因素。通过多因素生存分析,LVI被确认为OS的独立预后因素。亚组分析显示,LVI与淋巴结阴性患者的OS降低相关,而在淋巴结阳性病例中未观察到显著差异。

结论

我们的研究强调LVI是可切除ESCC患者的独立预后因素。LVI可能有助于对生存不良患者进行分层。